PATENT CLAIM ANALYSIS

Application Number: 16033446
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "387000"]

Abstract:
The invention relates to 1,3-diaza-spiro-[3.4]-octane derivatives, their preparation and use in medicine, particularly in various neurological disorders, including but not limited to pain, neurodegenerative disorders, neuroinflammatory disorders, neuropsychiatric disorders, substance abuse/dependence.

Claim (Index 34):
The compound according to  claim 1 , wherein R 5  means \u2014C 1 -C 6 -alkyl, linear or branched, saturated or unsaturated, unsubstituted or substituted with one, two, three or four substituents independently of one another selected from the group consisting of \u2014F, \u2014Cl, \u2014Br, \u2014I, \u2014CN, \u2014OH, \u2014O\u2014C 1 -C 4 -alkyl, \u2014O\u2014(CH 2 CH 2 \u2014O) 1-30 \u2014H, \u2014O\u2014(CH 2 CH 2 \u2014O) 1-30 \u2014CH 3 , \u2014C(\u2550O)OH, \u2014C(\u2550O)OC 1 -C 4 -alkyl, \u2014C(\u2550O)NH 2 , \u2014C(\u2550O)NHC 1 -C 4 -alkyl, \u2014C(\u2550O)N(C 1 -C 4 -alkyl) 2 , \u2014S(\u2550O)C 1 -C 4 -alkyl and \u2014S(\u2550O) 2 C 1 -C 4 -alkyl.

Metadata:
- Claim Count in Document: 57.0
- Percentile: 95.0
- Lexical Diversity: 1.34375
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15417953', '15969907', '15403741', '13483170', '12281317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7580625548295633
- 35 USC 102 Novelty (BERT): 0.535132328329991
- Combined Prediction Score: 0.7357695321796062
- Mean Citation Score: 333.198664
- Max Citation Score: 350.52203
- Similarity Product: 250.0934859142656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test